Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALLGregory W. Roloff, George Yaghmour, Noam E. Kopmar et al.|Journal of Clinical Oncology|2024Cited by 36